OP
$31.36
+0.15
(+0.48%)
As of Oct 20, 2026, 9:05 PM EDT
Price history
Option Care Health Inc (OPCH) is trading up at $31.36 (+0.48%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Option Care Health Inc revenue & net income history (FY2016–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $935.6M | $1.83B | $1.94B | $2.31B | $3.03B | $3.44B | $3.94B | $4.30B | $5.00B | $5.65B |
| Growth (year over year) | — | +95.4% | +6.1% | +19.1% | +31.3% | +13.4% | +14.7% | +9.1% | +16.2% | +13.0% |
| Gross profit | $262.1M | $446.0M | $422.2M | $513.0M | $682.3M | $779.6M | $866.9M | $981.2M | $1.01B | $1.09B |
| Gross margin | 28.0% | 24.4% | 21.8% | 22.2% | 22.5% | 22.7% | 22.0% | 22.8% | 20.3% | 19.3% |
| Operating income | −$11.0M | $27.3M | $38.3M | −$319.0K | $110.8M | $190.8M | $240.2M | $314.6M | $321.8M | $337.9M |
| Operating margin | −1.2% | 1.5% | 2.0% | −0.0% | 3.7% | 5.5% | 6.1% | 7.3% | 6.4% | 6.0% |
| Net income | −$42.8M | $3.88M | −$6.12M | −$75.9M | −$8.08M | $139.9M | $150.6M | $267.1M | $211.8M | $207.6M |
| Net margin | −4.6% | 0.2% | −0.3% | −3.3% | −0.3% | 4.1% | 3.8% | 6.2% | 4.2% | 3.7% |
| EPS (diluted) | −$0.55 | $0.03 | −$0.04 | −$0.49 | −$0.04 | $0.77 | $0.83 | $1.48 | $1.23 | $1.27 |
| Balance sheet | ||||||||||
| Cash and equivalents | $9.57M | $39.5M | $36.4M | $67.1M | $99.3M | $119.4M | $294.2M | $343.8M | $412.6M | $232.6M |
| Total assets | $605.0M | $603.1M | $1.43B | $2.59B | $2.65B | $2.79B | $3.11B | $3.22B | $3.42B | $3.46B |
| Total liabilities | $566.6M | $605.8M | $825.4M | $1.68B | $1.63B | $1.62B | $1.73B | $1.80B | $2.02B | $2.13B |
| Long-term debt | $433.4M | $478.9M | $535.2M | $1.28B | $1.12B | $1.06B | $1.06B | $1.06B | $1.10B | $1.15B |
| Shareholders' equity | $600.8M | — | $602.8M | $906.8M | $1.02B | $1.18B | $1.39B | $1.42B | $1.40B | $1.33B |
| Cash flow | ||||||||||
| Operating cash flow | −$42.5M | $37.9M | $24.4M | $39.5M | $127.4M | $208.6M | $267.5M | $371.3M | $323.4M | $258.4M |
| Capital expenditure | — | $25.0M | $26.3M | $28.3M | $26.9M | $25.6M | $35.4M | $41.9M | $35.6M | $41.3M |
| Free cash flow | — | $12.9M | −$1.85M | $11.2M | $100.5M | $182.9M | $232.2M | $329.4M | $287.8M | $217.1M |
| Share buybacks | — | — | — | — | — | $0 | $0 | $250.3M | $252.7M | $310.0M |
RevenueNet incomeNet margin (right axis, %)
| Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.23B | $1.28B | $1.35B | $1.33B | $1.42B | $1.44B | $1.47B | $1.35B |
| Growth (year over year) | +14.8% | +17.0% | +19.7% | +16.3% | +15.4% | +12.2% | +8.8% | +1.3% |
| Gross profit | $249.4M | $256.7M | $268.4M | $263.1M | $269.0M | $272.9M | $282.9M | $262.0M |
| Gross margin | 20.3% | 20.1% | 19.9% | 19.7% | 19.0% | 19.0% | 19.3% | 19.4% |
| Operating income | $80.7M | $85.1M | $87.0M | $79.2M | $82.7M | $84.5M | $91.5M | $72.5M |
| Operating margin | 6.6% | 6.7% | 6.5% | 5.9% | 5.8% | 5.9% | 6.2% | 5.4% |
| Net income | $53.0M | $53.9M | $60.1M | $46.7M | $50.5M | $51.8M | $58.5M | $45.3M |
| Net margin | 4.3% | 4.2% | 4.5% | 3.5% | 3.6% | 3.6% | 4.0% | 3.4% |
| EPS (diluted) | $0.30 | $0.31 | $0.36 | $0.28 | $0.31 | $0.32 | $0.36 | $0.29 |
| Balance sheet | ||||||||
| Cash and equivalents | $376.9M | $483.0M | $412.6M | $171.4M | $198.8M | $309.8M | $232.6M | $177.3M |
| Total assets | $3.35B | $3.43B | $3.42B | $3.31B | $3.38B | $3.48B | $3.46B | $3.38B |
| Total liabilities | $1.94B | $2.00B | $2.02B | $1.96B | $2.02B | $2.12B | $2.13B | $2.03B |
| Long-term debt | $1.11B | $1.11B | $1.10B | $1.10B | $1.10B | $1.16B | $1.15B | $1.15B |
| Shareholders' equity | $1.41B | $1.43B | $1.40B | $1.35B | $1.36B | $1.36B | $1.33B | $1.35B |
| Cash flow | ||||||||
| Operating cash flow | $195.7M | $160.4M | $36.1M | −$7.21M | $90.3M | $139.4M | $35.9M | −$12.1M |
| Capital expenditure | $9.78M | $9.67M | $10.3M | $9.37M | $9.10M | $9.20M | $13.6M | $9.05M |
| Free cash flow | $185.9M | $150.7M | $25.8M | −$16.6M | $81.2M | $130.2M | $22.2M | −$21.2M |
| Share buybacks | $78.1M | $42.0M | $92.6M | — | — | $62.5M | $95.1M | — |
From Option Care Health Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Option Care Health Inc
- Headquarters
- Bannockburn, Illinois From SEC filings, Oct 2026
Recent News (10)
-
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders? Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholder…
-
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders? Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholder…
-
-
-
Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day NAI500
-
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC. Option Care Health shareholders will receive just $32.05 per share, representing a total enterprise value of approximately $5.8 billion; Ademi LLP is investigating the deal price, benefits to company …
-
AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks Benzinga
-
AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks Are on Investors' Radars Today AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks Are on Investors' Radars Today TradingView
-
-
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International